These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17535864)

  • 21. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.
    Vahl N; Møller N; Lauritzen T; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3612-8. PubMed ID: 9360515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial.
    Li N; Zhou L; Zhang B; Dong P; Lin W; Wang H; Xu R; Ding H
    Dig Liver Dis; 2008 Jul; 40(7):554-9. PubMed ID: 18164672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omnitrope and Genotropin.
    Fuhr U; Tuculanu D; Berghout A; Balser S; Schwebig A; Saenger P
    Eur J Endocrinol; 2010 Jun; 162(6):1051-8. PubMed ID: 20332125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency.
    Sohmiya M; Kanazawa I; Kato Y
    Eur J Endocrinol; 2005 Feb; 152(2):211-5. PubMed ID: 15745928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
    Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
    Gill MS; Toogood AA; Jones J; Clayton PE; Shalet SM
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
    Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects.
    Okano M; Nishitani Y; Sato M; Ikekita A; Kageyama S
    Drug Test Anal; 2010; 2(11-12):548-56. PubMed ID: 21249726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.
    Bidlingmaier M; Kim J; Savoy C; Kim MJ; Ebrecht N; de la Motte S; Strasburger CJ
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2926-30. PubMed ID: 16720652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal IGF-I and enhanced IGFBP-3 response to very low rhGH dose in patients with dilated cardiomyopathy.
    Broglio F; Benso A; Arvat E; Aimaretti G; Gottero C; Granata R; Boghen MF; Bobbio M; Camanni F; Ghigo E
    J Endocrinol Invest; 2000 Sep; 23(8):520-5. PubMed ID: 11021768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
    Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patients.
    Laursen T; Flyvbjerg A; Jørgensen JO; Baxter RC; Christiansen JS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4310-4. PubMed ID: 11095473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency.
    Janssen YJ; Frölich M; Roelfsema F
    Br J Clin Pharmacol; 1999 Mar; 47(3):273-8. PubMed ID: 10215751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
    Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in mice.
    Bielohuby M; Schaab M; Kummann M; Sawitzky M; Gebhardt R; Binder G; Frystyk J; Bjerre M; Hoeflich A; Kratzsch J; Bidlingmaier M
    Endocrinology; 2011 Dec; 152(12):4764-76. PubMed ID: 21971154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety.
    Walvoord EC; de la Peña A; Park S; Silverman B; Cuttler L; Rose SR; Cutler G; Drop S; Chipman JJ
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2052-9. PubMed ID: 19336514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.